| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| AHSG | APOH | ENSPPYP00000016086 | ENSPPYP00000009611 | Alpha 2-HS glycoprotein. | APOH isoform 1. | 0.955 |
| AHSG | CR201_G0018235 | ENSPPYP00000016086 | ENSPPYP00000002402 | Alpha 2-HS glycoprotein. | ITIH2 isoform 4. | 0.663 |
| AHSG | FGL1 | ENSPPYP00000016086 | ENSPPYP00000020605 | Alpha 2-HS glycoprotein. | Fibrinogen like 1. | 0.511 |
| AHSG | ITIH2 | ENSPPYP00000016086 | ENSPPYP00000003279 | Alpha 2-HS glycoprotein. | ITIH2 isoform 1. | 0.663 |
| AHSG | ITIH3 | ENSPPYP00000016086 | ENSPPYP00000015436 | Alpha 2-HS glycoprotein. | Inter-alpha-trypsin inhibitor heavy chain H3; May act as a carrier of hyaluronan in serum or as a binding protein between hyaluronan and other matrix protein, including those on cell surfaces in tissues to regulate the localization, synthesis and degradation of hyaluronan which are essential to cells undergoing biological processes; Belongs to the ITIH family. | 0.572 |
| AHSG | SERPINA4 | ENSPPYP00000016086 | ENSPPYP00000006944 | Alpha 2-HS glycoprotein. | Kallistatin; Inhibits human amidolytic and kininogenase activities of tissue kallikrein. | 0.559 |
| AHSG | VTN | ENSPPYP00000016086 | ENSPPYP00000009099 | Alpha 2-HS glycoprotein. | VTN isoform 1. | 0.411 |
| APOH | AHSG | ENSPPYP00000009611 | ENSPPYP00000016086 | APOH isoform 1. | Alpha 2-HS glycoprotein. | 0.955 |
| APOH | CR201_G0018235 | ENSPPYP00000009611 | ENSPPYP00000002402 | APOH isoform 1. | ITIH2 isoform 4. | 0.801 |
| APOH | FGL1 | ENSPPYP00000009611 | ENSPPYP00000020605 | APOH isoform 1. | Fibrinogen like 1. | 0.898 |
| APOH | ITIH2 | ENSPPYP00000009611 | ENSPPYP00000003279 | APOH isoform 1. | ITIH2 isoform 1. | 0.801 |
| APOH | ITIH3 | ENSPPYP00000009611 | ENSPPYP00000015436 | APOH isoform 1. | Inter-alpha-trypsin inhibitor heavy chain H3; May act as a carrier of hyaluronan in serum or as a binding protein between hyaluronan and other matrix protein, including those on cell surfaces in tissues to regulate the localization, synthesis and degradation of hyaluronan which are essential to cells undergoing biological processes; Belongs to the ITIH family. | 0.606 |
| APOH | SERPINA4 | ENSPPYP00000009611 | ENSPPYP00000006944 | APOH isoform 1. | Kallistatin; Inhibits human amidolytic and kininogenase activities of tissue kallikrein. | 0.460 |
| CR201_G0018235 | AHSG | ENSPPYP00000002402 | ENSPPYP00000016086 | ITIH2 isoform 4. | Alpha 2-HS glycoprotein. | 0.663 |
| CR201_G0018235 | APOH | ENSPPYP00000002402 | ENSPPYP00000009611 | ITIH2 isoform 4. | APOH isoform 1. | 0.801 |
| CR201_G0018235 | ITIH2 | ENSPPYP00000002402 | ENSPPYP00000003279 | ITIH2 isoform 4. | ITIH2 isoform 1. | 0.808 |
| CR201_G0018235 | ITIH3 | ENSPPYP00000002402 | ENSPPYP00000015436 | ITIH2 isoform 4. | Inter-alpha-trypsin inhibitor heavy chain H3; May act as a carrier of hyaluronan in serum or as a binding protein between hyaluronan and other matrix protein, including those on cell surfaces in tissues to regulate the localization, synthesis and degradation of hyaluronan which are essential to cells undergoing biological processes; Belongs to the ITIH family. | 0.702 |
| CR201_G0018235 | SERPINA4 | ENSPPYP00000002402 | ENSPPYP00000006944 | ITIH2 isoform 4. | Kallistatin; Inhibits human amidolytic and kininogenase activities of tissue kallikrein. | 0.484 |
| CR201_G0018235 | TNFAIP6 | ENSPPYP00000002402 | ENSPPYP00000014339 | ITIH2 isoform 4. | TNF alpha induced protein 6. | 0.474 |
| CR201_G0018235 | VTN | ENSPPYP00000002402 | ENSPPYP00000009099 | ITIH2 isoform 4. | VTN isoform 1. | 0.665 |
